90 related articles for article (PubMed ID: 2662167)
1. [The hormone receptor content of breast cancers. Comparison of morphologic and biochemical methods of determination].
Neumann K; Rüschoff J; Horstmann A; Zwiorek L; Kalbfleisch H
Pathologe; 1989 May; 10(3):160-4. PubMed ID: 2662167
[No Abstract] [Full Text] [Related]
2. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases].
Fleige B; Pickartz H; Stein H
Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629
[No Abstract] [Full Text] [Related]
3. [Comparative morphologic and biochemical determinations of CEA and TPA in invasive breast cancers with special reference to lectin histochemistry and hormone receptor status].
Vogel J; Oehr P; Totović V; Bellmann O; Dworak O
Verh Dtsch Ges Pathol; 1985; 69():226-31. PubMed ID: 3913197
[No Abstract] [Full Text] [Related]
4. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
Prechtel D; Prechtel K
Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
[No Abstract] [Full Text] [Related]
5. [Interpretation of the estrogen receptor content of breast cancer].
Tuczek HV; Fritz P; Oeffinger B; Limbach HJ; Mischlinski A; Klein C; Wegner G
Geburtshilfe Frauenheilkd; 1990 Apr; 50(4):314-8. PubMed ID: 2358183
[TBL] [Abstract][Full Text] [Related]
6. [Tumor properties of primary tumors and local recurrence of breast cancer].
Torsten U; Opri F; Moreno-Richter I; Weitzel HK
Zentralbl Gynakol; 1993; 115(3):99-104. PubMed ID: 8385409
[TBL] [Abstract][Full Text] [Related]
7. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
Remmele W; Schicketanz KH
Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
[No Abstract] [Full Text] [Related]
8. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections].
Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J
Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912
[No Abstract] [Full Text] [Related]
9. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
Harrell JC; Dye WW; Allred DC; Jedlicka P; Spoelstra NS; Sartorius CA; Horwitz KB
Cancer Res; 2006 Sep; 66(18):9308-15. PubMed ID: 16982776
[TBL] [Abstract][Full Text] [Related]
10. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
[No Abstract] [Full Text] [Related]
11. Regional lymph node reactions related to hormone receptor status in female breast carcinoma.
Kosma VM; Syrjänen KJ
Arch Geschwulstforsch; 1985; 55(2):123-30. PubMed ID: 4004508
[TBL] [Abstract][Full Text] [Related]
12. [Estrogen receptors and clinical prognostic factors in breast cancer].
Hernández JL; Lera JM; Fakih A; Gómez Portilla A; Vicente F; Zornoza G
Rev Esp Oncol; 1983; 30(2):179-88. PubMed ID: 6097962
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors in breast cancer].
Jonat W; Eidtmann H; Friedrichs K
Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
[No Abstract] [Full Text] [Related]
14. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
Ronay G; Sponsel N; Merkle E; Tulusan AH
Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
[No Abstract] [Full Text] [Related]
15. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
[TBL] [Abstract][Full Text] [Related]
16. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
17. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
18. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
[TBL] [Abstract][Full Text] [Related]
19. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of histopathologic and immunohistochemical data (using the D5 antibody) and biochemical analysis in the study of estrogen receptors in breast carcinoma].
Bussolati G; Pietribiasi F; Gugliotta P; Conti G; Di Carlo F
Pathologica; 1987; 79(1059-1060):45-50. PubMed ID: 3441410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
